Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Cardinal Health, Inc.

Initial Statement of Beneficial Ownership

Insider	Title	Transaction Type	Shares Traded	% of Shares Traded	% Chg. in Shares	End of Filing Shares	Price	Transaction Value	Filing Date	Transaction Date
Jessica L. Mayer	Chief Legal & Compliance Officer Show All	Sale to Issuer (Sale to Issuer)	-422.0	-0.000177%	-3.1%	13.0K	212.3 - 212.3	-89.6K	02 Dec 2025	01 Dec 2025 - 01 Dec 2025
Deborah L. Weitzman	Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment Show All	Sale to Issuer (Sale to Issuer)	-551.0	-0.000231%	-1.0%	52.9K	212.3 - 212.3	-117.0K	02 Dec 2025	01 Dec 2025 - 01 Dec 2025
Mary C. Scherer	Senior VP & Chief Accounting Officer Show All	Sale to Issuer (Sale to Issuer)	-61.0	-0.000025%	-1.7%	3.5K	212.3 - 212.3	-12.9K	02 Dec 2025	01 Dec 2025 - 01 Dec 2025
Stephen M. Mason	Chief Executive Officer of GMPD segment Show All	Sale to Issuer (Sale to Issuer)	-595.0	-0.00025%	-2.3%	25.5K	212.3 - 212.3	-126.3K	02 Dec 2025	01 Dec 2025 - 01 Dec 2025
Ola M. Snow	Chief Human Resources Officer Show All	Sale to Issuer (Sale to Issuer)	-320.0	-0.000134%	-2.1%	15.3K	212.3 - 212.3	-67.9K	02 Dec 2025	01 Dec 2025 - 01 Dec 2025
Sudhakar Ramakrishna
Robert W. Musslewhite
Christine Ann M. Mundkur
Nancy Killefer
Gregory B. Kenny
Patricia Arlene Hemingway Hall
Akhil Johri
David C. Evans
Sheri H. Edison
Michelle M. Brennan
Robert William Azelby
Deborah L. Weitzman
Deborah L. Weitzman
Jason M. Hollar
Michelle D. Greene
Mary C. Scherer
Michelle D. Greene
Michelle D. Greene
Mary C. Scherer
Mary C. Scherer
Stephen M. Mason
Stephen M. Mason
Stephen M. Mason
Jason M. Hollar
Deborah L. Weitzman